Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 48, 2018 - Issue 6
197
Views
5
CrossRef citations to date
0
Altmetric
Animal Pharmacokinetics and Metabolism

Identification of three new phase II metabolites of a designer drug methylone formed in rats by N-demethylation followed by conjugation with dicarboxylic acids

, , , , , & show all
Pages 618-625 | Received 05 May 2017, Accepted 28 Jun 2017, Published online: 25 Jul 2017

References

  • Barrios L, Grison-Hernando H, Boels D, et al. (2016). Death following ingestion of methylone. Int J Legal Med 130:381–5.
  • Bauer A, Schöpfer J, Sachs H, et al. (2013). Fatality after intake of methylone, MDMA and amphetamine: a case report. Toxichem Krimtech 80:343.
  • Bossong MG, Van Dijk JP, Niesink RJ. (2005). Methylone and mCPP, two new drugs of abuse? Addict Biol 10:321–3.
  • Carbone PN, Carbone DL, Carstairs SD, Luzi SA. (2013). Sudden cardiac death associated with methylone use. Am J Forensic Med Pathol 34:26–8.
  • Cawrse BM, Levine B, Jufer RA, et al. (2012). Distribution of methylone in four postmortem cases. J Anal Toxicol 36:434–9.
  • Ellefsen KN, Concheiro M, Huestis MA, et al. (2015). Quantification of methylone and metabolites in rat and human plasma by liquid chromatography-tandem mass spectrometry. Forens Toxicol 33:202–12.
  • European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). (2016). European drug report: trends and developements. Available at: http://www.emcdda.europa.eu/system/files/publications/2637/TDAT16001ENN.pdf [last accessed on 6 Janury 2017].
  • Jacob P, Shulgin AT. (1996). Novel n-substituted-2-amino-30,40-methylene-dioxypropiophenones. US Patent WO1996039133 A1, filed 6 June 1996, and issued 12 December 1996.
  • Kamata HT, Shima N, Zaitsu K, et al. (2006). Metabolism of the recently encountered designer drug, methylone, in humans and rats. Xenobiotica 36:709–23.
  • Kelly JP. (2011). Cathinone derivatives: a review of their chemistry, pharmacology and toxicology. Drug Test Anal 3:439–53.
  • Kovács K, Toth AR, Kereszty EM. (2012). A new designer drug: methylone related death (in Hungarian with English abstract). Orv Hetil 153:271–6.
  • Li Q, Zhang S, Berthiaume JM, et al. (2014). Novel approach in LC-MS/MS using MRM to generate a full profile of acyl–CoAs: discovery of acyl-dephospho–CoAs. J Lipid Res 55:592–602.
  • Linhart I, Himl M, Židková M, et al. (2016). Metabolic profile of mephedrone: identification of nor-mephedrone conjugates with dicarboxylic acids as a new type of xenobiotic phase II metabolites. Toxicol Lett 240:114–21.
  • López-Arnau R, Martínez–Clemente J, Pubill D, et al. (2013). An integrated pharmacokinetic and pharmacodynamic study of a new drug of abuse, methylone, a synthetic cathinone sold as “bath salts”. Prog Neuropsychopharmacol Biol Psychiatry 45:64–72.
  • McIntyre IM, Hamm CE, Aldridge L, Nelson CL. (2013). Acute methylone intoxication in an accidental drowning-a case report. Forensic Sci Int 231:e1–3.
  • Meyer MR, Wilhelm J, Peters FT, et al. (2010). Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography–mass spectrometry. Bioanal Chem 97:1225.
  • Mueller DM, Rentsch KM. (2012). Generation of metabolites by an automated online metabolism method using human liver microsomes with subsequent identification by LC-MS(n), and metabolism of 11 cathinones. Anal Bioanal Chem 402:2141–51.
  • Newman JC, He W, Verdin E. (2012). Mitochondrial protein acylation and intermediary metabolism: regulation by sirtuins and implications for metabolic disease. J Biol Chem 287:42436–43.
  • Pearson JM, Hargraves TL, Hair LS, et al. (2012). Three fatal intoxications due to methylone. J Anal Toxicol 36:444–51.
  • Pedersen AJ, Petersen TH, Linnet K. (2013). In vitro metabolism and pharmacokinetic studies on methylone. Drug Metab Disposition 41:1247–55.
  • Pozo OJ, Ibáñez M, Sancho JV, et al. (2015). Mass spectrometric evaluation of mephedrone in vivo human metabolism: identification of phase I and Phase II metabolites, including a novel succinyl conjugate. Drug Metab Disposition 43:248–57.
  • Rosenbaum CD, Carreiro SP, Babu KM. (2012). Here today, gone tomorrow…and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines. J Med Toxicol 8:15–32.
  • Sørensen LK. (2011). Determination of cathinones and related ephedrines in forensic whole-blood samples by liquid-chromatography–electrospray tandem mass spectrometry. J Chromatogr B 879:727–36.
  • Spiller HA, Ryan ML, Weston RG, Jansen J. (2011). Clinical experience with and analytical confirmation of “bath salts” and “legal highs” (synthetic cathinones) in the United States. Clin Toxicol 49:499–505.
  • Tekulve K, Alexander A, Tormoehlen L. (2014). Seizures associated with synthetic cathinone exposures in the pediatric population. Pediatr Neurol 51:67–70.
  • Uralets V, Rana S, Morgan S. Ross W. (2014). Testing for designer stimulants: metabolic profiles of 16 synthetic cathinones excreted free in human urine. J Anal Toxicol 38:233–41.
  • US Drug Enforcement Administration (US DEA). (2014). Special report: synthetic cannabinoids and synthetic cathinones reported in NFLIS, 2010–2013. Available at: https://www.nflis.deadiversion.usdoj.gov/desktopmodules/reportdownloads/reports/syncannabsyncath.pdf [last accessed 6 January 2017].
  • Warrick BJ, Wilson J, Hedge M, et al. (2012). Lethal serotonin syndrome after methylone and butylone ingestion. J Med Toxicol 8:65.
  • World Health Organization (WHO). (2014). Methylone (bk-MDMA). Critical Review Report. Thirty-sixth Meeting Geneva. Available at: https://www.unodc.org/documents/commissions/CND/Mandate_and_Functions/Report_36th_WHO_ECDD.pdf [last accessed 6 January 2017].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.